Emergent BioSolutions Inc. (EBS)

NYSE: EBS · Real-Time Price · USD

6.35

-0.48 (-7.03%)

At close: Jun 27, 2025, 4:00 PM

6.75

+0.40 (6.30%)

After-hours: Jun 27, 2025, 7:59 PM EDT

Emergent BioSolutions Market Cap

Emergent BioSolutions has a market cap or net worth of $344.66 million as of June 27, 2025. Its market cap has increased by 2.95% in one year.

Market Cap

344.66M

Enterprise Value

868.26M

1-Year Change

2.95%

Ranking

#3240

Market Cap Chart

Since November 15, 2006, Emergent BioSolutions's market cap has increased from $320.80M to $344.66M, an increase of 7.44%. That is a compound annual growth rate of 0.39%.

Market Cap History

Date	Market Cap	% Change
Jun 26, 2025	370.70M	-28.44%
Dec 31, 2024	518.00M	316.06%
Dec 29, 2023	124.50M	-78.87%
Dec 30, 2022	589.20M	-74.81%
Dec 31, 2021	2.34B	-50.75%
Dec 31, 2020	4.75B	70.50%
Dec 31, 2019	2.79B	-7.78%
Dec 31, 2018	3.02B	57.00%
Dec 29, 2017	1.92B	44.63%
Dec 30, 2016	1.33B	-14.64%
Dec 31, 2015	1.56B	52.38%
Dec 31, 2014	1.02B	22.29%
Dec 31, 2013	836.10M	45.38%
Dec 31, 2012	575.10M	-5.00%
Dec 30, 2011	605.40M	-25.67%
Dec 31, 2010	814.50M	94.58%
Dec 31, 2009	418.60M	-46.42%
Dec 31, 2008	781.20M	419.07%
Dec 31, 2007	150.50M	-50.82%
Dec 29, 2006	306.00M	-4.61%

View and export this data all the way back to 2006. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Eli Lilly and Company	711.28B
Johnson & Johnson	366.40B
AbbVie	327.47B
Novo Nordisk	301.06B
UnitedHealth Group	273.97B
Abbott Laboratories	239.05B
Novartis AG	231.01B
AstraZeneca	216.45B

Market Cap Rankings